[Application of Next-Generation Sequencing in Screening of Thalassemia Gene in 11212 Pregnant Women in Suxian and Beihu Districts of Chenzhou City, Hunan Province]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Feb;29(1):188-192. doi: 10.19746/j.cnki.issn.1009-2137.2021.01.029.
[Article in Chinese]

Abstract

Objective: To understand the carrying rate, gene mutation frequency and composition ratio of thalassemia in pregnant women in Suxian and Beihu districts of Chenzhou, Hunan Province.

Methods: Thalassemia gene in 11 212 samples was analyzed by using Next-Generation Sequencing.

Results: Among the 11 212 samples, 938 were diagnosed as thalassemia, in which 618 (5.51%) were diagnosed as α-thalassemia, 268 (2.39%) as β-thalassemia, 29(0.26%)as abnormal hemoglobin and 23 (0.21%) as αβ-thalassemia. The gene mutations of --SEA /αα(40.29%) and -α3.7/αα(37.7%) in α-thalassemia were the most common, while for β- thalassemia, the most commonly gene mutation were β41-42M/βN(24.26%) and β654M/βN(23.88%). The detection rate of rare type α,β-thalassemia gene was 0.19%(21/11 212), 0.53%(59/11 212), respectively.

Conclusion: The carrying rate of thalassemia in pregnant women is 8.37% in Suxian and Beihu districts of Chenzhou city, and the genotypes are complex. Next-Generation Sequencing can detect rare thalassemia genes and new gene mutations effectively.

题目: 高通量测序技术在湖南省郴州市苏仙、北湖两区11212例孕妇地中海贫血基因筛查中的应用.

目的: 了解湖南省郴州市苏仙、北湖两区孕妇地中海贫血(简称地贫)携带率、基因突变频率及构成比.

方法: 采用高通量测序技术对11 212例样本进行地贫基因分析.

结果: 检出地贫患者938例,其中α-地贫618例,β-地贫268例,异常血红蛋白29例,αβ-复合地贫23例,检出率分别为5.51%、2.39%、0.26%、0.21%。α-地贫基因突变以--SEA /αα(40.29%)及-α3.7 /αα(37.7%)为主,β-地贫以β41-42M/βN(24.26%)及β654M/βN(23.88%)为主。罕见型α、β地贫基因的检出率分别为0.19%(21/11 212)、0.53%(59/11 212).

结论: 郴州市苏仙、北湖两区孕妇地贫基因携带率为8.37%,基因型复杂。高通量测序技术能有效地检出罕见地贫基因及新的基因突变.

MeSH terms

  • China
  • Female
  • Genotype
  • Hemoglobins, Abnormal*
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Mutation
  • Pregnancy
  • Pregnant Women
  • alpha-Thalassemia* / genetics
  • beta-Thalassemia* / genetics

Substances

  • Hemoglobins, Abnormal